Home › Non-Small Cell Lung Cancer › Illinois › Arlington Heights
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Arlington Heights, IL
Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Arlington Heights. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Nagre-recruitPhase 3
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 3
- Illinois Cancer Specialists, Arlington Heights
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Nagre-recruitPhase 3
- Illinois Cancer Specialists, Arlington Heights
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
Nagre-recruitObservasyonal na pag-aaral
- Northwest Oncology & Hematology, Elk Grove Village · 6 mi ang layo
An External Control Arm Study in Non-Small Cell Lung Cancer
Nagre-recruitObservasyonal na pag-aaral
- Northwest Oncology and Hematology, Rolling Meadows · 2 mi ang layo
- Northwest Oncology and Hematology, Elk Grove · 6 mi ang layo
- Northwest Oncology and Hematology, Hoffman Estates · 6 mi ang layo
- at 1 pa
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Nagre-recruitPhase 2/3
- Local Institution - 007-883-A, Arlington Heights
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Nagre-recruitPhase 3
- Illinois Cancer Specialists, Arlington Heights
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Nagre-recruitPhase 3
- Northwest Oncology & Hematology, Barrington · 9 mi ang layo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Nagre-recruitPhase 2/3
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Advocate Good Shepherd Hospital, Barrington · 9 mi ang layo
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Arlington Heights
- Colorectal Cancer12 pag-aaral
- Kanser sa Baga9 pag-aaral
- Kanser sa Suso7 pag-aaral
- Pagkabigo ng Puso7 pag-aaral
- Metastatic Cancer6 pag-aaral
- Ulcerative Colitis6 pag-aaral
- Colon Cancer6 pag-aaral
- Kanser sa Ovary5 pag-aaral
- Obesity5 pag-aaral
- Overweight5 pag-aaral
- Kanser sa Prostate3 pag-aaral
- Mga Kondisyon ng Balat3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.